SARS-CoV-2 infection and adverse outcomes in users of ACE inhibitors and angiotensin-receptor blockers: a nationwide case-control and cohort analysis
Danish study (13,501 SARS-CoV-2 positive cases and 1,088,695 controls) found ACE inhibitor/ angiotensin receptor blocker use was not associated with a consistently increased rate of SARS-CoV-2 infection or with adverse outcomes of SARS-CoV-2 infection.
Source:
Thorax